Reino Unido #6499 (v.4)
Datos básicos
- Notificada en
-
G/MA/QR/N/GBR/2 30/09/2022
- Validez de la versión
-
30/09/2022 -
20/12/2022
Versión anterior v.4
- Miembro informante
- Reino Unido
- En vigor desde
- Fecha de supresión
- En vigor
- Descripción general
-
Measures to regulate exports of certain medicaments
- Fundamento jurídico nacional
-
Regulation 43(2) of the Human Medicines Regulations 2012 requiring wholesale dealers to ensure continued supply of medicinal products so that the needs of patients in the UK are met. Further details can be found through: https://www.legislation.gov.uk/uksi/2012/1916/contents/made
The date restrictions came into effect varies by medicine; this is specified for each medicine on the list, updated on 24 June 2022 and available on gov.uk at:
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1042790/restricted-medicines-list-december-2021-v3.csv/preview - Mecanismo administrativo
-
The list of medicines is maintained by the Department of Health & Social Care
These measures are reviewed regularly
A full change log of previous measures, from October 2019, can be found here:
https://www.gov.uk/government/publications/medicines-that-cannot-be-parallel-exported-from-the-uk
Medicines included on this list meet the following conditions:
• The medicine is required to meet the needs of UK patients
• The medicine is currently in shortage or risk of being in shortage
• The export of the medicine would contribute to a shortage, or risk of shortage, of that medicine in the UK - Entidades responsables
-
Department of Health and Social Care
- Versión del SA
-
HS 2022
- Signatura de la OMC a que se hace referencia
Metadatos
- Justificaciones en el marco de la OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Notificada como: Article XX(b) GATT Protection of human, animal or plant life or health - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
- Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- CP-X
Signatura |
---|
CP-X
|
Líneas arancelarias
300241
|
3002.41.90
|
1. Heading 3002 - Classification: Human blood; animal blood prepared for therapeutic, prophylactic o...
|
|
300420
|
3004.20.00
|
2. Heading 3004 - Classification Medicaments consisting of mixed or unmixed products for therapeutic...
|
|
300431
|
3004.31.00
|
2. Heading 3004 - Classification Medicaments consisting of mixed or unmixed products for therapeutic...
|
|
300432
|
3004.32.00
|
2. Heading 3004 - Classification Medicaments consisting of mixed or unmixed products for therapeutic...
|
|
300439
|
3004.39.00
|
2. Heading 3004 - Classification Medicaments consisting of mixed or unmixed products for therapeutic...
|
|
300449
|
3004.49.00
|
2. Heading 3004 - Classification Medicaments consisting of mixed or unmixed products for therapeutic...
|
|
300490
|
3004.90.00
|
2. Heading 3004 - Classification Medicaments consisting of mixed or unmixed products for therapeutic...
|
|